U.S., Europe, and Japan AI in Endoscopy Market to Reach Over USD 367.5 Million by 2031, Advancing at a Strong CAGR of 26.4% | Transparency Market Research

The rapid integration of artificial intelligence (AI) into endoscopic procedures is revolutionizing the global healthcare landscape, particularly across the U.S., Europe, and Japan. As hospitals and clinicians shift toward precision-based diagnostics and treatment planning, AI-driven endoscopic systems are emerging as high-value tools that enhance accuracy, efficiency, and clinical outcomes. The AI in endoscopy market across these regions was valued at USD 46.4 Mn in 2022 and is forecast to surpass USD 367.5 Mn by 2031, reflecting an impressive CAGR of 26.4% from 2023 to 2031.

Access key findings and insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85988

Market Overview: AI in endoscopy refers to the application of advanced algorithms to support the detection, diagnosis, characterization, and management of gastrointestinal (GI) abnormalities. AI-enabled systems are capable of real-time image analysis, enhanced visualization, automated detection of polyps, and improved classification of lesions.

The market is expanding rapidly due to rising GI disease burden, increased colorectal cancer incidence, advancements in computer-aided detection (CADe) and computer-aided diagnosis (CADx), and growing adoption of minimally invasive diagnostic procedures. The U.S. continues to lead technological innovation, while Europe's healthcare investment environment and Japan's aging population are also contributing significantly to market growth.

Key Drivers of Market Growth

1. Rise in Prevalence of Colorectal Cancer
One of the strongest market catalysts is the increasing prevalence of colorectal cancer (CRC), the third most commonly diagnosed cancer globally. In 2020, CRC accounted for 10% of all cancer cases and 9.4% of global cancer deaths. As early detection significantly improves survival rates, AI-based endoscopy plays a critical role in identifying precancerous lesions with higher precision.
AI-assisted systems improve the adenoma detection rate (ADR). Research shows that a 1% increase in ADR reduces the risk of CRC by 3%, highlighting the value of AI in enabling earlier intervention and more accurate diagnoses.

2. Technological Advancements in Endoscopic Imaging
AI systems integrated with high-definition imaging, multi-modal imaging, and advanced visualization support clinicians in real-time decision-making. These systems help detect subtle lesions often overlooked by the human eye.

3. Supportive Regulatory and Healthcare Ecosystems
Regulatory bodies such as the U.S. FDA and European Medical Device Regulation (MDR) are increasingly approving AI-driven solutions, enabling greater adoption in clinical settings.

4. Growing Adoption of Minimally Invasive Procedures
Patients and healthcare providers prefer minimally invasive diagnostics for reduced recovery time, lower risk, and improved accuracy. AI enhances these procedures with faster and more reliable outcomes.

Latest Market Trends
AI-Integrated Imaging Systems
Companies are launching AI-powered modules capable of detecting polyps, assessing bleeding, identifying early cancerous changes, and assisting in real-time clinical decision-making.

Cloud-Based AI Platforms
Cloud-enabled AI models support faster data processing, remote analysis, and continuous software updates.

Collaborative R&D and Academic Partnerships
Universities, hospitals, and medtech firms are working together on large datasets to refine AI algorithms and boost diagnostic precision.

Personalized GI Diagnostics
Machine learning models are increasingly being used to deliver personalized diagnosis and follow-up treatment planning.

Key Players and Industry Leaders

Major companies shaping the market include:
• Medtronic plc
• Wision A.I.
• Olympus Corporation Ltd
• Fujifilm Corporation
• Pentax Corporation
• NEC Corporation
• Magentiq Eye Inc.
• Iterative Scopes
• ENDOANGEL Medical Technology Co., Ltd.
• Waycen Inc.
• Others Players

These companies are developing cutting-edge AI modules for CAD, CADe, and CADx applications, strengthening their market positions through strategic collaborations, product launches, and expansion initiatives.

Buy this Premium Research Report for exclusive, in-depth insights - https://www.transparencymarketresearch.com/checkout.php?rep_id=85988<ype=S

Recent Developments

• In May 2022, Wision A.I. signed a partnership agreement with Micro-Tech Endoscopy USA, the U.S. subsidiary of the global medical device company Micro-Tech (Nanjing) Co. Ltd, which develops and supplies diagnostic and therapeutic devices in the gastroenterology space. Micro-Tech will be the U.S. GI endoscopy distributor of EndoScreener, an AI-assisted polyp detection software used during colonoscopy procedures.

• In April 2021, the GI Genius intelligent endoscopy module, developed by Medtronic in collaboration with Cosmo Pharmaceuticals, received de novo clearance from the U.S. Food and Drug Administration (FDA). The GI Genius module is the first and only commercially available artificial intelligence (AI)-based computer-aided detection (CADe) method for detecting colorectal polyps.

Market Opportunities and Challenges

Opportunities
1. Expansion of AI into Therapeutic Endoscopy
AI could assist not only in detection but also in automated classification and therapeutic decision-making.

2. Adoption in Ambulatory Surgical Centers and Private Clinics
Growing demand for outpatient GI procedures provides significant market potential.

3. Integration with Robotics and Autonomous Navigation
Future endoscopes may be semi-autonomous with embedded AI guidance systems.

Challenges
1. Data Privacy and Integration Concerns
Handling large volumes of patient data requires strict compliance with privacy regulations.

2. High Implementation Costs
AI-powered devices and integration require substantial capital investments.

3. Lack of Standardization Across Platforms
Variability in datasets and training protocols can affect algorithm performance across devices.

Future Outlook

The AI in endoscopy market across the U.S., Europe, and Japan is set for exponential growth driven by:

• Technological innovation in imaging and detection
• Increased governmental and institutional investments
• A global shift toward early screening for colorectal and GI cancers
• Rapid expansion of cloud-based AI and machine learning models

Europe is expected to strengthen its position through broader adoption of AI-driven endoscopic solutions supported by regulatory flexibility and healthcare funding. The U.S. market will benefit from strong FDA support and early technology adoption, while Japan's aging population will continue driving demand for advanced AI endoscopic procedures.

Between 2023 and 2031, the market is expected to witness robust development, transforming diagnostic workflows and significantly improving patient care outcomes.

Market Segmentation

By Type
• CADe
• CADx
• CADe/CADx
• Others

By Product
• Hardware
• Software
• Services

By Application
• Polyp Detection
• Bleeding Detection
• Early Cancer Identification
• Cancer Staging
• Polyp Sizing
• Others (Characterization, Quality Indicators)

By End-user
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics

Countries Covered
• U.S.
• Europe: Germany, UK, France, Italy, Spain, Rest of Europe
• Japan

Why Buy This Report?

• Comprehensive Market Insights: Detailed analysis of market size, projections, competitive landscape, and technological advancements.
• Data-Driven Forecasting: Reliable quantitative data backed by industry research for informed decision-making.
• Competitive Advantage: Understand strategies adopted by leading companies and emerging players.
• Opportunity Mapping: Identify untapped market segments, potential investments, and future growth areas.
• Strategic Recommendations: Actionable insights for manufacturers, investors, healthcare providers, and technology developers.
• Global and Regional Analysis: Covers the U.S., Europe, and Japan with in-depth country-level insights.

Explore Latest Research Reports by Transparency Market Research:

Artificial Intelligence in Operating Room Market: https://www.transparencymarketresearch.com/artificial-intelligence-in-operating-room-market.html

Patient Engagement Solutions Market: https://www.transparencymarketresearch.com/patient-engagement-solutions-market.html

Prosthetic Disc Nucleus Market: https://www.transparencymarketresearch.com/prosthetic-disc-nucleus-pdn-market.html

Cystatin C Assay Market: https://www.transparencymarketresearch.com/cystatin-c-assay-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact Us:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.